References
[1]
Boese AC, Le QE, Pham D, et al. Neural stem cell therapy for subacute and chronic ischemic stroke. Stem Cell Res Ther. 2018, 9(1): 154.
[2]
Francardo V, Schmitz Y, Sulzer D, et al. Neuroprotection and neurorestoration as experimental therapeutics for Parkinson’s disease. Exp Neurol. 2017, 298(Pt B): 137-147.
[3]
Gao L, Xu W, Li T, et al. Stem cell therapy: A promising therapeutic method for intracerebral hemorrhage. Cell Transplant. 2018, doi: 10.1177/0963689718773363.
[4]
Samoilova EM, Kalsin VA, Kushnir NM, et al. Adult neural stem cells: Basic research and production strategies for neurorestorative therapy. Stem Cells Int. 2018, 2018: 4835491, doi: 10.1155/2018/4835491.
[5]
Sharma A, Sane H, Gokulchandran N, et al. An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability. Stem Cell Res Ther. 2018, 9(1): 19.
[6]
Steinberg GK, Kondziolka D, Wechsler LR, et al. Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: A phase 1/2a study. Stroke 2016, 47(7): 1817-1824.
[7]
Venkat P, Shen Y, Chopp M, et al. Cell-based and pharmacological neurorestorative therapies for ischemic stroke. Neuropharmacology 2018, 134(Pt B): 310-322.
[8]
Venkat P, Chopp M, Chen J. Cell-based and exosome therapy in diabetic stroke. Stem Cells Transl Med. 2018, 7(6): 451-455.
[9]
Huang H, Young W, Chen L, et al. Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2017). Cell Transplantation 2018, 27(2): 310-324.
[10]
Huang H, Mao G, Feng S, et al. 2016 yearbook of neurorestoratology. Journal of Neurorestoratology 2017, 5: 111-115.
[11]
Huang H, Skaper S, Mao G, et al. 2017 Yearbook of Neurorestoratology. Journal of Neurorestoratology 2018, 6: 65-73.
